May 13 (Reuters) - Orgenesis Inc:
* ORGENESIS ANNOUNCES CELL-BASED VACCINE PLATFORM TARGETING COVID-19 AND OTHER EXISTING AND EMERGING VIRAL DISEASES
* ORGENESIS INC - IS MOVING FORWARD WITH PLANNED ANIMAL TESTING FOR ITS CELL-BASED VACCINE PLATFORM IN COVID-19
* ORGENESIS INC - HAS NOT YET SUBMITTED ANY SUCH PLANS OR DATA TO FDA OR ANY OTHER REGULATORY BODY Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.